| Pharmaceutical active ingredients: |
| Methyltestosterone |
| Available forms, composition and doses of Neo-Hombreol-M: |
| N / A |
| Neo-Hombreol-M medical category: |
| Human:Anabolic steroidsTestosterone deficiency treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03BA02 - MethyltestosteroneG03EK01 - Methyltestosterone |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Neo-Hesna | Carbazochrome Sodium Sulfonate | Takeda Pharmaceutical |
| Neohetramine | Thonzylamine | Unidentified Pharmaceutical Company |
| Neohexal | Methenamine | Riedel Zabinka Produtos Quimicos e Farmaceuticos |
| Neo-Hibernex | Promazine | Unidentified Pharmaceutical Company |
| Neo-Hombreol F | Testosterone | Unidentified Pharmaceutical Company |
| Neo-Homobreol M | Methyltestosterone | Unidentified Pharmaceutical Company |
| Neo-HS | Butabarbital; Meprobamate | Neolab |
| Neo-Hydeltrasol | Neomycin Sulfate; Prednisolone Sodium Phosphate | Merck |
| Neohydrin | Chlormerodrin | Unidentified Pharmaceutical Company |
| Neo-Hydro | Hydrocortisone Acetate; Neomycin Sulfate | Upha Corporation; Beacons Pharmaceuticals; G. Streuli |